MX2018015607A - Microestructura de acido hialuronico que tiene excelentes caracteristicas de solubilidad. - Google Patents

Microestructura de acido hialuronico que tiene excelentes caracteristicas de solubilidad.

Info

Publication number
MX2018015607A
MX2018015607A MX2018015607A MX2018015607A MX2018015607A MX 2018015607 A MX2018015607 A MX 2018015607A MX 2018015607 A MX2018015607 A MX 2018015607A MX 2018015607 A MX2018015607 A MX 2018015607A MX 2018015607 A MX2018015607 A MX 2018015607A
Authority
MX
Mexico
Prior art keywords
skin
microstructure
hyaluronic acid
solubility characteristics
present
Prior art date
Application number
MX2018015607A
Other languages
English (en)
Spanish (es)
Inventor
Soo Kim Jae
Chang Kwon Soon
Jin Park Sang
Original Assignee
Endoderma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endoderma Co Ltd filed Critical Endoderma Co Ltd
Publication of MX2018015607A publication Critical patent/MX2018015607A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Cosmetics (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
MX2018015607A 2016-06-16 2017-06-16 Microestructura de acido hialuronico que tiene excelentes caracteristicas de solubilidad. MX2018015607A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160074985 2016-06-16
PCT/KR2017/006342 WO2017217818A1 (ko) 2016-06-16 2017-06-16 용해 특성이 우수한 히알루론산 마이크로구조체

Publications (1)

Publication Number Publication Date
MX2018015607A true MX2018015607A (es) 2019-03-14

Family

ID=60663275

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018015607A MX2018015607A (es) 2016-06-16 2017-06-16 Microestructura de acido hialuronico que tiene excelentes caracteristicas de solubilidad.

Country Status (9)

Country Link
US (1) US11013670B2 (zh)
EP (1) EP3473242A4 (zh)
JP (1) JP6900405B2 (zh)
KR (1) KR101973801B1 (zh)
CN (1) CN109310625A (zh)
BR (1) BR112018075703A2 (zh)
MX (1) MX2018015607A (zh)
TW (2) TWI718576B (zh)
WO (1) WO2017217818A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102025546B1 (ko) 2017-11-22 2019-09-26 단국대학교 천안캠퍼스 산학협력단 히알루론산-칼슘 복합체 및 알지네이트를 포함하는 약물 전달체
TR201922945A2 (tr) * 2019-12-31 2021-07-26 Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi Osteoartri̇t tedavi̇si̇ i̇çi̇n propoli̇s i̇çeri̇kli̇ yeni̇ bi̇r vi̇skoelasti̇k formülasyonu ve bunun üreti̇m yöntemi̇
EP3854375A1 (en) * 2020-01-23 2021-07-28 Paean Aesthetics Inc Micro-spicule composition to control its shape and method for producing the same
US11129788B1 (en) * 2020-03-24 2021-09-28 Elc Management Llc Sprayable film forming compositions for improving the performance of topical preparations
KR102122208B1 (ko) * 2020-04-07 2020-06-12 주식회사 라파스 마이크로니들 패치를 이용한 최소 침습적 아토피 피부염 검사 방법 및 마이크로니들 패치를 포함하는 최소 침습적 아토피 검사 키트
FR3109153B1 (fr) * 2020-04-10 2022-07-15 Teoxane SA Compositions à base d’au moins deux glycosaminoglycanes
KR20230024668A (ko) * 2021-08-12 2023-02-21 주식회사 페로카 마이크로니들 패치
CN114311721B (zh) * 2021-12-27 2023-09-08 青岛农业大学 一种可食用、可生物降解餐具的制备方法
KR102643334B1 (ko) * 2022-08-23 2024-03-05 주식회사 큐에이치바이오 가교 히알루론산 및 생체 적합성 미립자를 포함하는 피부 필러 조성물, 및 그 제조방법

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7963997B2 (en) * 2002-07-19 2011-06-21 Kensey Nash Corporation Device for regeneration of articular cartilage and other tissue
JP3420851B2 (ja) 1994-12-06 2003-06-30 株式会社資生堂 癒着防止剤
JP4210231B2 (ja) * 2004-03-25 2009-01-14 株式会社資生堂 皮膚のシワを改善する美容方法及びシワ改善具
FR2909560B1 (fr) 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique
BRPI0906016A2 (pt) * 2008-02-27 2015-06-30 Kci Licensing Inc Sistema para curar uma ferida em um local do tecido, método para facilitar a remoção de um campo cirúrgico de um local do tecido e kit
JP5267910B2 (ja) * 2008-02-28 2013-08-21 コスメディ製薬株式会社 マイクロニードルアレイ
ES2691388T3 (es) 2008-10-07 2018-11-27 Tuo Jin Microagujas poliméricas de transición de fases
WO2012008722A2 (ko) * 2010-07-12 2012-01-19 신풍제약 주식회사 조직 증강용 충전 조성물
US20140200508A1 (en) 2012-06-29 2014-07-17 Isaac D. Cohen Microneedles Comprising One Or More Cosmetic Ingredients
ES2851234T3 (es) 2012-09-13 2021-09-03 Avraham Amir Dispositivos de suministro y métodos para aumento cutáneo
KR101435888B1 (ko) 2012-10-23 2014-09-01 연세대학교 산학협력단 히알루론산을 이용한 생분해성 마이크로니들 제조방법
CA2896188C (en) * 2012-12-21 2021-02-23 Corium International, Inc. Microarray for delivery of therapeutic agent and methods of use
CN104095761A (zh) * 2013-04-08 2014-10-15 上海汇林医药科技有限公司 一种高分子聚合物微针贴剂及其应用
JP6906885B2 (ja) * 2014-11-14 2021-07-21 ロレアル しわを減少させるためのマイクロニードルシート
WO2016129967A1 (ko) 2015-02-13 2016-08-18 주식회사 엔도더마 가교된 히알루론산 하이드로젤을 이용한 마이크로구조체 및 이의 제조방법
CN104921961B (zh) 2015-05-25 2017-11-17 成都凤磐生物科技有限公司 一种多效修复的可降解生物微针贴
MY188756A (en) 2015-12-28 2021-12-29 Endoderma Co Ltd Microstructure for transdermal absorption and method for manufacturing same

Also Published As

Publication number Publication date
BR112018075703A2 (pt) 2019-04-02
EP3473242A4 (en) 2019-06-19
JP2019523680A (ja) 2019-08-29
KR20170142127A (ko) 2017-12-27
TW201938175A (zh) 2019-10-01
EP3473242A1 (en) 2019-04-24
US20190336411A1 (en) 2019-11-07
TW201808310A (zh) 2018-03-16
US11013670B2 (en) 2021-05-25
WO2017217818A1 (ko) 2017-12-21
JP6900405B2 (ja) 2021-07-07
CN109310625A (zh) 2019-02-05
TWI675666B (zh) 2019-11-01
KR101973801B1 (ko) 2019-04-30
TWI718576B (zh) 2021-02-11

Similar Documents

Publication Publication Date Title
MX2018015607A (es) Microestructura de acido hialuronico que tiene excelentes caracteristicas de solubilidad.
EP4279064A3 (en) Drug delivery from hydrogels
PH12017501956A1 (en) Compositions of obeticholic acid and methods of use
WO2016090287A3 (en) Transdermal cannabinoid formulations
MX2020009390A (es) Suministro transdermico y/o dermico de agentes activos lipofilicos.
MX2019014548A (es) Derivado de n2,n4-difenilprimidin-2,4-diamina, metodo para la preparacion del mismo, y una composicion farmaceutica que contiene el mismo como ingrediente activo para la prevencion o tratamiento de cancer.
PH12015502280A1 (en) Transdermal delivery system comprising donepezil or its salt
MX2017003623A (es) Parche de opipramol.
GB2491328A (en) Immediate/delayed drug delivery
MX2022008277A (es) Composiciones de gel para administracion transdermica para maximizar las concentraciones de farmaco en el estrato corneo y suero, y metodos de uso de las mismas.
EP3575314A3 (en) Glucagon derivatives
NZ727709A (en) Pharmaceutical composition comprising 5alpha-reductase inhibitor
MX2011007817A (es) Formulacion farmaceutica o alimenticia de liberacion controlada y proceso para su preparacion.
NZ709620A (en) Pharmaceutical formulation comprising an insoluble corticosteroid and a soluble corticosteroid
WO2018143552A3 (ko) 탈모방지 또는 발모촉진용 주사용 조성물
WO2017176045A3 (ko) 효율적인 피부 천공을 위한 마이크로니들 구조
MX2020014208A (es) Agentes terapeuticos para administracion subcutanea optimizados.
MX2017000041A (es) Formulaciones de liberacion inmediata disuasivas de abuso que comprenden polisacaridos no celulosicos.
CA3010788A1 (en) Methods of administering vasopressors
MX2020003044A (es) Dispositivo de administración transdérmica de dextrometorfano.
MX2021012029A (es) Composicion farmaceutica de corticosteroide soluble.
MX2022006770A (es) Dispersiones solidas de bendamustina e infusion continua.
EP3587392A8 (en) Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases
EP3100744A4 (en) Composition for accelerating penetration through skin, preparation for transdermal administration, and skin patch preparation
MX2018006921A (es) Métodos y composiciones para el tratamiento de úlceras gástricas.